Ultragenyx price target raised to $46 from $45 at Wells Fargo
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Wells Fargo raises Ultragenyx price target to $46 with current price $26.24; price has moved -3.51 since signal, signaling upside potential.
Target: $46
Posted price: $26.24
Analyst firm: Wells Fargo
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.